Pharma As As Service

Covid-19 is the first of what I expect will be many "bio-pollution" crises du jour going forward.  Experience with Ebola and similar previous outbreaks has triggered an unprecedented global response, and brings to light some challenges familiar of software development, e.g.time-to-market, rapid scalability, etc.

The software industry has already changed with this in mind, though driven by vendor's self-interest.  How would Big Pharma look, if adopting the same strategies?  Think about how EUL"A" trump the common-law rights of users, how products are forever in "beta" i.e. unfit to be guaranteed safe for release, how systems are left open for vendor-pushed updates, etc.

Can we wait for formal FDA etc. approval of tests, vaccines, etc.?

What will happen if we don't?